Average monthly pharmaceutical research backlog was $420 million for the third quarter of 2007, an increase of 5% when compared to the average for the third quarter of fiscal 2006.
Although we saw some improvement in bid proposals in the quarter, we also experienced some delays signing contracts and cancellations. As noted last quarter, a significant contract cancellation occurred late in April, reducing our backlog to $425 million at the beginning of May and we have experienced a further decline in reported backlog for the third quarter. As of July 31, 2007 our backlog was $410 million.
Average monthly backlog during the quarter
-------------------------------------------------------------------------
Fiscal 2005 - Quarter 1 $ 315
Quarter 2 305
Quarter 3 315
Quarter 4 340
Fiscal 2006 - Quarter 1 370
Quarter 2 400
Quarter 3 400
Quarter 4 430
Fiscal 2007 - Quarter 1 450
Quarter 2 450
Quarter 3 420
-------------------------------------------------------------------------
-------------------------------------------------------------------------
We reported an operating loss of $5 million for MDS Pharma Services, a
69% reduction compared to the operating loss of $16 million reported for
the prior year
'/>"/>
| SOURCE MDS Inc. Copyright©2007 PR Newswire. All rights reserved |